Evidence map›Paper›PMID 32348781›Full record

ArticleCell host & microbe2020

A Genomic Toolkit for the Mechanistic Dissection of Intractable Human Gut Bacteria.

Jordan E Bisanz, Paola Soto-Perez, Cecilia Noecker, Alexander A Aksenov, Kathy N Lam, Grace E Kenney, Elizabeth N Bess, Henry J Haiser, Than S Kyaw, Feiqiao B Yu and 7 more

Abstract read
In one paragraph

Article in Cell host & microbe, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed.

  1. Trial
  2. Review
  3. Anaerobic riboflavin degradation by human gutJournal of bacteriology · 2026
    Article
  4. Research square · 2026
    Article
  5. bioRxiv : the preprint server for biology · 2026
    Article
  6. Article
  7. Female-enrichedbioRxiv : the preprint server for biology · 2026
    Article
  8. Anaerobic riboflavin degradation by human gutbioRxiv : the preprint server for biology · 2026
    Article
  9. Review
  10. Urease in acetogenicGut microbes · 2025
    Article
  11. Article
  12. Article
  13. Journal of the American Chemical Society · 2025
    Article
  14. Microbiome Single Cell Atlases Generated with a Commercial Instrument.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jordan E BisanzDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA.
Paola Soto-PerezDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA.
Cecilia NoeckerDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA.
Alexander A AksenovCollaborative Mass Spectrometry Innovation Center, Department of Pediatrics, Center for Microbiome Innovation, Department of Pharmacology, Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, CA 92093, USA.
Kathy N LamDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA.
Grace E KenneyDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Elizabeth N BessDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA.
Henry J HaiserFaculty of Arts and Sciences Center for Systems Biology, Harvard University, Cambridge, MA 02138, USA.
Than S KyawDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA.
Feiqiao B YuChan Zuckerberg Biohub, San Francisco, CA 94158, USA.
Vayu M RekdalDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Connie W Y HaDepartment of Medicine, Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Suzanne DevkotaDepartment of Medicine, Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Emily P BalskusDepartment of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Pieter C DorresteinCollaborative Mass Spectrometry Innovation Center, Department of Pediatrics, Center for Microbiome Innovation, Department of Pharmacology, Skaggs School of Pharmacy and Pharmaceutical Sciences, San Diego, CA 92093, USA.
Emma Allen-VercoeMolecular and Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, Canada.
Peter J TurnbaughDepartment of Microbiology and Immunology, University of California San Francisco, San Francisco, CA 94143, USA; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA. Electronic address: peter.turnbaugh@ucsf.edu.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
ZIDOVUDINE &LAMIVUDINE &NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFM01RR001271 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KESSLER, DAVID A · 1985 to 2006
$22.7M
GENETICS OF EUCARYOTIC AND PROCARYOTIC ORGANISMST32GM007810 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ASHRAFI, KAVEH, NARLIKAR, GEETA J · 1985 to 2020
$15.1M
UCSF Nutrition Obesity Research CenterP30DK098722 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTIAN VAISSE · 2015 to 2026
$14.6M
Microbial Pathogenesis and Host DefenseT32AI060537 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joanne N. Engel · 2004 to 2026
$6.5M
Predicting and preventing drug metabolism by the human gut microbiomeR01HL122593 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Peter James Turnbaugh · 2016 to 2026
$5.7M
Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapyR01AR074500 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Renuka Rajendra Nayak, Jose U. Scher · 2019 to 2026
$4.1M
(PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomesR21CA227232 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ATREYA, CHLOE E., TURNBAUGH, PETER JAMES · 2018 to 2019
$378k
NCI NIH HHS R21 CA227232NCRR NIH HHS M01 RR001271NHLBI NIH HHS R01 HL122593NIAID NIH HHS T32 AI060537NIAMS NIH HHS R01 AR074500NIDDK NIH HHS P30 DK098722NIGMS NIH HHS T32 GM007618NIGMS NIH HHS T32 GM007810
6 · The paper itself

Abstract

Despite the remarkable microbial diversity found within humans, our ability to link genes to phenotypes is based upon a handful of model microorganisms. We report a comparative genomics platform for Eggerthella lenta and other Coriobacteriia, a neglected taxon broadly relevant to human health and disease. We uncover extensive genetic and metabolic diversity and validate a tool for mapping phenotypes to genes and sequence variants. We also present a tool for the quantification of strains from metagenomic sequencing data, enabling the identification of genes that predict bacterial fitness. Competitive growth is reproducible under laboratory conditions and attributable to intrinsic growth rates and resource utilization. Unique signatures of in vivo competition in gnotobiotic mice include an adhesin enriched in poor colonizers. Together, these computational and experimental resources represent a strong foundation for the continued mechanistic dissection of the Coriobacteriia and a template that can be applied to study other genetically intractable taxa.

Indexed as

GenomicsActinobacteriaAnimalsAnti-Bacterial AgentsBacteriaDissectionGastrointestinal MicrobiomeGastrointestinal TractGenes, BacterialGerm-Free LifeHumansMetagenomeMetagenomicsMiceMicrobial Sensitivity TestsMultigene FamilyAnti-Bacterial Agentscolonizationcomparative genomicsCoriobacteriiaEggerthella lentafitnesshuman gut microbiomemetabolismmetabolomics

Identifiers

PMID32348781
PMCPMC7292766

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.